Work

Optimizing Repetitive Transcranial Magnetic Stimulation for Major Depressive Disorder

Year: 2023
Type: dissertation
Abstract: Repetitive transcranial magnetic stimulation (rTMS) is a well-established and effective intervention in MDD, with an advantageous side-effect profile over medication. Unfortunately, widespread adoption of rTMS has been impeded by several obstacles limiting clinical accessibility, including high costs of acquisition and operation, technical challenges because of the current complexity of the procedure, and the lack of validated and scalable biomarkers to help predict treatment outcome. To address these issues, we explored novel rTMS delivery methods, including parabolic coils with broad stimulation areas allowing easy targeting, safe and well-tolerated low-frequency 1 Hz stimulation delivered on the most affordable FDA-approved rTMS devices, an open-room setting allowing a single technician to attend to multiple patients, custom-made equipment reducing costs, and performed schedule optimization using treatment acceleration. We subsequently attempted to maximize effects by optimizing stimulation parameters. Lastly, we researched heart rate variability (HRV) as a potential biomarker to predict treatment outcomes. Our initial chart review studies helped us determine that the use of parabolic coils combined with 1 Hz rTMS was safe and well-tolerated in the treatment of MDD. Our second study showed that accelerated 1 Hz rTMS with parabolic coils was also safe, well-tolerated. We also showed that an open-room setting was feasible and that our custom-made rTMS equipment was reliable. Given the limited clinical effects observed in those studies, we researched an even more intensive accelerated 1 Hz rTMS protocol in our third study and found evidence of increased effectiveness. Lastly, we did not observe any significant association between baseline pre-treatment resting-state HRV and clinical outcomes. In the final part of this thesis, we summarize our findings and discuss their implications for the treatment of MDD. We conclude by discuss the various limitations inherent to this preliminary work and potential future directions. Given its established efficacy in MDD and its lower side-effect profile compared to medication, efforts should be made to make rTMS more accessible. Our work proposes several ways to improve rTMS by simplifying procedures to reduce costs and therefore potentially increasing accessibility at the community level, increase clinical effects and help with patient selection.
Language: English
Subfield: Neurology
Open Access status: green
OpenAlex ID: W7133079137
Cites: 288
Cited by:
Related to: 10